Doug Bettenhausen This is Me

 Web References

1. 1. SALIX SAYS PUBLIC CITIZEN REPORT MISLEADING

   www.fdanews.com/dailies/drugda - [Cached]

   Published on: 3/21/2006   Last Visited: 3/21/2006

   Doug Bettenhausen, executive director of medical affairs at Salix, told FDAnews that Public Citizen did not clarify that out of the 21 cases of kidney failure, only one was attributable to Visicol while the other 20 were attributable to Fleet Phospho-Soda.
   
   Bettenhausen also noted the patient on Visicol "was not an ideal patient for treatment" because he suffered from renal dysfunction and was taking an ACE inhibitor, which places people at higher risk for dehydration. Relevant warnings were clearly stated in the package insert, he added.
   
   "Those patients have to be very carefully maintained on any drugs," Bettenhausen said regarding the patient on Visicol. "What appears to have happened was that he wasn't properly hydrated," he said.

2. 2. Newswire Display

   www.nephronline.com/core/newsw - [Cached]

   Published on: 1/1/2005   Last Visited: 3/29/2006

   Doug Bettenhausen, executive director of medical affairs at Salix, told FDAnews that Public Citizen did not clarify that out of the 21 cases of kidney failure, only one was attributable to Visicol while the other 20 were attributable to Fleet Phospho-Soda. Bettenhausen also noted the patient on Visicol "was not an ideal patient for treatment" because he suffered from renal dysfunction and was taking an ACE inhibitor, which places people at higher risk for dehydration. Relevant warnings were clearly stated in the package insert, he added. "Those patients have to be very carefully maintained on any drugs," Bettenhausen said regarding the patient on Visicol. "What appears to have happened was that he wasn't properly hydrated," he said.

3. 3. newsobserver.com | Business

   www.newsobserver.com/104/story - [Cached]

   Published on: 3/18/2003   Last Visited: 3/18/2006

   The drugs' package inserts include warnings for physicians and patients to exercise caution, said Doug Bettenhausen, a pharmacist and Salix's executive director for medical affairs."You lose lots of fluids with sodium phosphate," Bettenhausen said.